PACIRA BIOSCIENCES, INC. Public Float
PACIRA BIOSCIENCES, INC. (PCRX) had Public Float of $757.50 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $757.50M.
- 2024-06-28: Entity Public Float $930.10M.
- 2023-06-30: Entity Public Float $1.30B.
- 2022-06-30: Entity Public Float $1.90B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $757.50M 10-K · filed 2026-02-26 |
| 2024-06-28 | $930.10M 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.30B 10-K · filed 2024-02-29 |
| 2022-06-30 | $1.90B 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.60B 10-K · filed 2022-02-28 |
| 2020-06-30 | $1.60B 10-K · filed 2021-03-01 |
| 2019-06-28 | $848.30M 10-K · filed 2020-02-21 |
| 2018-06-29 | $1.30B 10-K · filed 2019-02-28 |
| 2017-06-30 | $1.90B 10-K · filed 2018-02-28 |
| 2016-06-30 | $949.00M 10-K · filed 2017-03-01 |
| 2015-06-30 | $1.30B 10-K · filed 2016-02-25 |
| 2014-06-30 | $1.50B 10-K · filed 2015-02-24 |
| 2013-06-28 | $606.37M 10-K · filed 2014-02-25 |
| 2012-06-30 | $282.65M 10-K · filed 2013-03-07 |
| 2011-06-30 | $65.89M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |